查詢結果分析
相關文獻
- Risk Factors for the Development of Neuropathic Pain in Type 2 DM Patients
- Neuropathic Pain in Type 2 Diabetes Mellitus Patients
- Effect of Glycemic Control on Electrophysiologic Changes of Diabetic Neuropathy in Type2 Diabetic Patients
- 治療第二型糖尿病藥物Repaglinide
- 從JNCVI及UKPDS談第二型糖尿病的血壓控制
- 從「英國前瞻性糖尿病研究」談糖尿病的血糖控制
- 第二型糖尿病之口服藥物治療趨勢
- Increased Urinary Endothelin-1 Excretion in Newly Diagnosed Type 2 Diabetic Patients
- 末稍糖尿病神經病變--目前的建議和未來期待的預防及治療
- 從ABCD及FACET臨床試驗談鈣離子阻斷劑在糖尿病病人的使用
頁籤選單縮合
題 名 | Risk Factors for the Development of Neuropathic Pain in Type 2 DM Patients=第二型糖尿病併發神經痛的危險因子 |
---|---|
作 者 | 曹心怡; 徐惠娟; 郭書麟; 王庭荃; 簡志誠; | 書刊名 | 疼痛醫學雜誌 |
卷 期 | 23:1 2013.03[民102.03] |
頁 次 | 頁9-14 |
分類號 | 415.6681 |
關鍵詞 | 糖尿病神經痛; 糖尿病神經病變; 肌肉骨骼疼痛; 第二型糖尿病; Diabetic neuropathic pain; Diabetic neuropathy; Musculoskeletal diseases; Type 2 diabetes mellitus; |
語 文 | 英文(English) |
中文摘要 | 糖尿病神經病變是最好發的糖尿病併發症。而糖尿病神經病變的危險因子卻少為人所研究。過去只知道與高血壓,身高,年紀,高膽固醇血症有關。中央健保局的資料庫提供單一且集中的資料庫,藉由此資料庫的分析,得知糖尿病診斷前一年內已有肌肉骨骼痛者,在診斷糖尿病的五年內產生糖尿病神經痛的危險性相對提高。 |
英文摘要 | Objective: Diabetic neuropathy is the most common complication of type 2 diabetes mellitus. Diabetic neuropathic pain is the type of excruciatingly refractory pain with sensorimotor neuropathy which is the most common type of neuropathy. The purpose of this study is to examine the risk factors of diabetic neuropathic pain. Method: We studied possible risk factors for developing diabetic neuropathy in the Taiwan National Health Insurance Research Database (NHIRD). This nationwide population based study extracted data in the Taiwan NHIRD from 1998 to 2006. A total of 52,190 patients diagnosed with type 2 diabetic mellitus within a one-year period of musculoskeletal disease (MSD) in between 1998 and 2002 were included together with 7,670 non-MSD patients as a comparison cohort. Cox proportional hazard regressions were conducted to compute hazard ratios, after the adjustment for comorbid medical disorders and socio-demographic status. Results: Results indicated that 13.8% of the T2DM patients with MSD experienced a diabetic neuropathic pain episode during this 5-year period compared with 9.8% of patients in the comparison cohort. The adjusted hazard of diabetic neuropathic pain was significantly higher (1.308 times, 95% Confidence Interval 1.2101.413) for patients with MSD, relative to the comparison cohort. The association persisted in further analyses stratified by hypertension, coronary heart diseases, and age. Conclusion: MSD was identified as an independent risk factor for subsequent diabetic neuropathic pain. Therefore a comprehensive multidisciplinary approach is needed to optimize primary and secondary prevention of diabetic neuropathic pain in patients with MSD. |
本系統中英文摘要資訊取自各篇刊載內容。